<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/13613115-E290-45AC-BAA6-83D88728749C"><gtr:id>13613115-E290-45AC-BAA6-83D88728749C</gtr:id><gtr:name>Xian Jiaotong University</gtr:name><gtr:address><gtr:line1>28 Xianningxi West Road</gtr:line1><gtr:line2>710049 Xi'an City</gtr:line2><gtr:line3>Shaanxi Province</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/13613115-E290-45AC-BAA6-83D88728749C"><gtr:id>13613115-E290-45AC-BAA6-83D88728749C</gtr:id><gtr:name>Xian Jiaotong University</gtr:name><gtr:address><gtr:line1>28 Xianningxi West Road</gtr:line1><gtr:line2>710049 Xi'an City</gtr:line2><gtr:line3>Shaanxi Province</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EAC6D94B-F564-4561-8B3D-1C81E583E1B7"><gtr:id>EAC6D94B-F564-4561-8B3D-1C81E583E1B7</gtr:id><gtr:firstName>Wuding</gtr:firstName><gtr:surname>Zhou</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/893D66CD-2721-4DA1-BC08-7050127B4B3A"><gtr:id>893D66CD-2721-4DA1-BC08-7050127B4B3A</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Sacks</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601202"><gtr:id>A6E09A1F-787A-4F27-87FD-2A122C497F7E</gtr:id><gtr:title>Receptors for C3a and C5a modify dendritic cell function in alloreactive T cell responses and allograft rejection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601202</gtr:grantReference><gtr:abstractText>Defence against invasive organisms such as bacteria and viruses begins with an immediate inflammatory response, which is followed a few days later by more lasting immunity provided by white cells known as T lymphocytes. In much the same way that T lymphocytes, with the help of the innate inflammatory response, eliminates invading organisms, these defences recognise as foreign, organ transplants from an unrelated donor, leading to rejection of the donor organ. By studying proteins of the inflammatory response called complement, work in our laboratory and at other centres has already shown that T lymphocytes can only function properly in the presence of complement; without complement transplanted kidney survives for much longer. Our aim is to learn how complement drives the immune response and to develop treatments that prevent complement from causing disease. We believe that complement acts on the immune system through an intermediary type of cell (dendritic cell) that passes on instructions to resting T lymphocytes alerting them to the presence of foreign material. We will carefully examine the ability of dendritic cells to detect activated complement fragments and examine whether blockade of this ability of dendritic cells to sense complement activation will blunt the capacity of the immune system to generate harmful T cells, and thus reduce the risk of transplant rejection. If we are successful in showing how complement stimulates harmful T cells, this may offer a valuable means to block the immune response against organ transplants and thus prevent rejection.</gtr:abstractText><gtr:technicalSummary>Accumulating evidence suggests that local production of complement (C) in antigen presenting cells (APCs), such as dendritic cells (DCs), is crucial for full T cell activation and development of a Th1 phenotype; however, the underlying mechanisms of action of complement on APCs are uncertain. In the proposed research we will test the hypothesis that local production of complement and its activation, at the sites of interstitial space and interface with environment where DCs reside, generate potent inflammatory molecules (e.g. C3a, C5a) that bind to their receptors on DCs resulting in DC activation; and this process is critical for the development of DC function and DC-mediated T cell responses. To investigate this, we will initially assess if C3a and C5a liberated in these circumstances bind to their respective receptors on myeloid DCs and lead to DC activation. We will then determine if such C3a receptor (C3aR) or C5a receptor (C5aR) engagement modulates DC effector functions in alloreactive T cell response in vivo and in vitro, using C3aR-/- or C5aR-/- DCs, C3a or C5a agonists/antagonists. Once we have established if blockade or deficiency of C3aR (or C5aR) in DCs reduces the potency of DCs to stimulate alloreactive T cells and promotes regulatory T cell development, we will study the relevance of the findings to solid-organ transplantation. Using a model of mouse kidney transplantation that is well established in our laboratory, we will investigate if donor kidney and/or recipients lacking C3aR (or C5aR) exhibit improved allograft outcomes. In support of this hypothesis, our preliminary data show that C3aR and C5aR are synthesised in myeloid DCs, and that C3a is present in DC culture supernatant. Additionally, we find that blockade or deficiency of C3aR (or C5aR) in DCs leads to a tolerogenic DC cytokine profile with lowered capacity by about two-thirds for alloreactive T cell stimulation. Thus, C3aR (and/or C5aR) engagement on APCs offers a potential mechanism by which local production of complement regulates the antidonor T cell response, and could therefore contribute to allograft rejection. We anticipate the proposed research will inform our understanding of the way in which innate immunity regulates the adaptive immune response via complement receptor. Manipulation of C by receptor blockade could provide a new direction for preventing immune mediated injury including transplant rejection.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-01</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>446650</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine Xi'an Jiaotong</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Core Research Laboratory</gtr:department><gtr:description>Natural killer cell regulation by complement</gtr:description><gtr:id>25A801FD-5F3C-4F6B-A9B7-1B43A1755160</gtr:id><gtr:impact>Work in progress</gtr:impact><gtr:partnerContribution>Performing experiments</gtr:partnerContribution><gtr:piContribution>Help with experimental design and interpretation of results</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar - Sir William Dunn School of Pathology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>63E7B835-9FEB-4223-88A0-BB53B25585AD</gtr:id><gtr:impact>Interest and further discussions followed

Strengthened links in support of application for UKRMP Immunology Stem Cell Hub</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Inhibitor of inflammation</gtr:description><gtr:id>23F120AE-4BB1-4219-88E1-0523516AD6C9</gtr:id><gtr:impact>Work in progress</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Membrane targetted C5a receptor inhibitor</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/343EBFFA-8623-4A8C-8B4C-9EE590A3035F"><gtr:id>343EBFFA-8623-4A8C-8B4C-9EE590A3035F</gtr:id><gtr:title>New boundaries for complement in renal disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c12df69d984c2e012769607eaadd6a4"><gtr:id>8c12df69d984c2e012769607eaadd6a4</gtr:id><gtr:otherNames>Sacks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5FBF1D4E-1B04-4D73-8291-CD628B638C3D"><gtr:id>5FBF1D4E-1B04-4D73-8291-CD628B638C3D</gtr:id><gtr:title>Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96E6BA6D-5129-40A4-8317-73C6D5FFE9D3"><gtr:id>96E6BA6D-5129-40A4-8317-73C6D5FFE9D3</gtr:id><gtr:title>Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46D8519B-C693-47A0-97A5-3E6B185FE876"><gtr:id>46D8519B-C693-47A0-97A5-3E6B185FE876</gtr:id><gtr:title>Anaphylatoxins in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6625BB1D-4A09-467D-9D76-36A566BB87E7"><gtr:id>6625BB1D-4A09-467D-9D76-36A566BB87E7</gtr:id><gtr:title>The role of complement in the early immune response to transplantation.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff9ec214617661fdfb7e5229c6dcdcbf"><gtr:id>ff9ec214617661fdfb7e5229c6dcdcbf</gtr:id><gtr:otherNames>Sacks SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F611CF1-1ECE-40E9-A15B-7F94CD62C527"><gtr:id>8F611CF1-1ECE-40E9-A15B-7F94CD62C527</gtr:id><gtr:title>Complement in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a316adfc796e81a38c1044af9c04fdd4"><gtr:id>a316adfc796e81a38c1044af9c04fdd4</gtr:id><gtr:otherNames>Asgari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60B93340-4BA1-4078-A538-CEB9A79A02BC"><gtr:id>60B93340-4BA1-4078-A538-CEB9A79A02BC</gtr:id><gtr:title>The role of complement in regulating the alloresponse.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c12df69d984c2e012769607eaadd6a4"><gtr:id>8c12df69d984c2e012769607eaadd6a4</gtr:id><gtr:otherNames>Sacks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9BA12AB2-7252-4B9E-9132-6049C51B6E7F"><gtr:id>9BA12AB2-7252-4B9E-9132-6049C51B6E7F</gtr:id><gtr:title>The new face of anaphylatoxins in immune regulation.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a4a3cd997f841d3d0f26f99aa36df9b"><gtr:id>7a4a3cd997f841d3d0f26f99aa36df9b</gtr:id><gtr:otherNames>Zhou W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43623B7F-0790-4ECA-9690-B4F9FCEB1422"><gtr:id>43623B7F-0790-4ECA-9690-B4F9FCEB1422</gtr:id><gtr:title>Deficiency of C5aR prolongs renal allograft survival.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/99f6924f8765fc02490873fd4b290945"><gtr:id>99f6924f8765fc02490873fd4b290945</gtr:id><gtr:otherNames>Li Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BF64200-A158-4F7A-9F21-66EAB6C44492"><gtr:id>2BF64200-A158-4F7A-9F21-66EAB6C44492</gtr:id><gtr:title>Dendritic cell function in allostimulation is modulated by C5aR signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97491B0F-23CE-4C50-9CE2-100D0328D548"><gtr:id>97491B0F-23CE-4C50-9CE2-100D0328D548</gtr:id><gtr:title>Expression of complement components, receptors and regulators by human dendritic cells.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7686B485-C040-4C9D-9E76-359485D507B2"><gtr:id>7686B485-C040-4C9D-9E76-359485D507B2</gtr:id><gtr:title>Complement Therapeutics</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c12df69d984c2e012769607eaadd6a4"><gtr:id>8c12df69d984c2e012769607eaadd6a4</gtr:id><gtr:otherNames>Sacks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A559B2B9-A450-45C1-8BB3-B950E1C40868"><gtr:id>A559B2B9-A450-45C1-8BB3-B950E1C40868</gtr:id><gtr:title>Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D63787F0-7576-499F-B15A-C4D25E6992A6"><gtr:id>D63787F0-7576-499F-B15A-C4D25E6992A6</gtr:id><gtr:title>Donor specific transplant tolerance is dependent on complement receptors.</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b45355c9a618881be06116dbdce75346"><gtr:id>b45355c9a618881be06116dbdce75346</gtr:id><gtr:otherNames>Bartel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2932EAF5-3E87-4082-B0F7-002658DEBF2F"><gtr:id>2932EAF5-3E87-4082-B0F7-002658DEBF2F</gtr:id><gtr:title>C3a and C5a promote renal ischemia-reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3FB171A-AE7C-462F-96F9-3E91D18D82FF"><gtr:id>E3FB171A-AE7C-462F-96F9-3E91D18D82FF</gtr:id><gtr:title>Locally produced and activated complement as a mediator of alloreactive T cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience (Scholar edition)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c880ba39733a8c5294d52b49ae5760"><gtr:id>f5c880ba39733a8c5294d52b49ae5760</gtr:id><gtr:otherNames>Lalli PN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1945-0516</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28186320-3E61-418A-BA51-9E6E4E0B27C7"><gtr:id>28186320-3E61-418A-BA51-9E6E4E0B27C7</gtr:id><gtr:title>The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.</gtr:title><gtr:parentPublicationTitle>Inflammation &amp; allergy drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1871-5281</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601202</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>